Novartis Consumer Health Reshuffled, Functional Foods On Sales Block
This article was originally published in The Tan Sheet
Executive Summary
Novartis is reorganizing its consumer health division by grouping together three businesses - OTC drugs, infant and baby and medical nutrition - and operating animal health and Ciba Vision as separate units, the firm stated during a year-end analysts call Feb. 7
You may also be interested in...
Novartis Tavist ND Loratadine Tablets Carry Geneva’s Marketing Exclusivity
Geneva Pharmaceuticals initially will market the first generic competition to Schering-Plough's OTC Claritin behind pharmacy counters
Novartis Tavist ND Loratadine Tablets Carry Geneva’s Marketing Exclusivity
Geneva Pharmaceuticals initially will market the first generic competition to Schering-Plough's OTC Claritin behind pharmacy counters
Novartis Tavist ND Loratadine Tablets Carry Geneva’s Marketing Exclusivity
Geneva Pharmaceuticals initially will market the first generic competition to Schering-Plough's OTC Claritin behind pharmacy counters